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Abstract
We describe a case of a man, 42 years old, submitted to successful fibrinolitic strategy with rTPA
in acute mitralic prosthesis valve thrombosis and ipomobility of one emidisk. There aren't a
consensus agreement in therapeutic strategy but we may support the approach of some authors
that employ fibrinolisis in patients without absolute or relative controindications and if thrombus
dimension is less than 1 cm otherwise they make use of heparin therapy in non obstructive
thrombosis with successive transesophageal echocardiography evaluation for the efficacy and the
later indication for thrombolisis or surgery treatment.
Introduction
The high incidence (7–34%/year) of thromboembolic
risk in patients with valvular prosthesis without a correct
administration of anticoagulant therapy has been demon-
strated since the last 40 years. This risk is higher in patients
older than 50 years old, with spherical prosthesis (actually
not yet used), with prosthesis in mitralic location and in
patients with association of atrial fibrillation [1-5]. How-
ever mechanical prosthesis have a long last and are more
functional safely compared with the biological one; so
mechanical devices are preferable implanted in young
people even if they need a correct anticoagulation.
So some authors propose, as gold standard for oral anti-
coagulant therapy, to maintain INR (international nor-
malized ratio) value between 2 and 3 (or 2.5–3.5) in all
patients, between 3 and 4.5 in patients with old caged
prosthesis and in association with antiplatlet therapy
(ASA 100 mg) in patients with double prosthesis, ball
devices, prosthetic valved conduit, patients with coronar-
osclerosis or by coronary artery bypass grafts in order to
reduce thromboembolic risk [6].
Case presentation
We describe a case of a man, 42 years old, that became to
our emergency room for dyspnoea and tachycardia with
fever (37.5°C) since two days with signs of congestive
heart failure (pulmonary rantoli without ascites and pedal
oedema).
The patient was carrier of a mitralic mechanical emidisc
prosthesis (Sorin n°31 Bicarbon), implanted 7 years ago
for mixomatosus valve with severe mitralic insufficiency
from LA e LP mitral valve prolapse. The patient referred a
lack in anticoagulant therapy with dicumarolic drug for
about one week.
The electrocardiogram showed sinusal tachycardia (138
bpm) and left anterior bundle brunch emiblock.
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Laboratory results demonstrated leukocytosis (17,5 ×
1000/ul), inadequate values of scoagulation (INR 1.2, PT
13.1 sec, PT 98%), D-Dimer 569 ng/ml.
Chest radiograph described signs of pulmonary conges-
tion. So the patients was treated with diuretics, inotropic
agents at kidneys dosage and antibiotic e.v.
The transthoracic echocardiogram color Doppler showed
a mechanical prosthesis in mitralic position with ipomo-
bility of one emidisc and a transoesophageal one con-
firmed the presence of a thrombus on the atrial side, left
atrial enlargement, trans prosthesis gradient major than
30 mmHg and medium 28 mmHg (fig. 1, 2, 3)
In consideration of these reports the patient started a
treatment with not fractionated heparin e.v. and fibrinoli-
sis (rTPA) with improved in symptoms and hemody-
namic signs. An echocardiogram color Doppler carried
out after thrombolisis showed a marked reduction in
transvalvular prosthetic gradient (ΔP medium 5 mmHg)
confirmed by a transoesophageal echocardiography (fig.
4) that pointed out a resolution of the thrombotic image
but evidenced the presence of two filaments moving
towards the atrial side.
The patients started with oral anticoagulant therapy in
association with the not fractioned heparin e.v until the
achieved objective of an adequate anticoagulant value
(INR between 2.5 and 3.5). after 10 days another echocar-
diogram color Doppler was performed with the evidence
of complete resolution of prosthetic thrombosis.
Discussion
Prosthetic thrombosis is a frightened complication of
mechanical mitralic valve especially if there is a lack in the
anticoagulant therapy.
The incidence of thrombosis in mechanical valve (and
also in biological one) is between 0.1 and 5.7% pts/year
in patients with uncorrected anticoagulant therapy [1-4].
The role of transesophageal echocardiography is essential
to distinguish malfunctioning due to prosthesis obstruc-
tion or to prosthetic thrombosis with ipomobility of the
Transesophageal echocardiography: Doppler CW on mitral  prosthesis valve with the evidence of transvalvular gradient Figure 1
Transesophageal echocardiography: Doppler CW on 
mitral prosthesis valve with the evidence of transval-
vular gradient.
Transesophageal echocardiography: 2D evidence of mitral  prosthesis valve thrombosis Figure 2
Transesophageal echocardiography: 2D evidence of 
mitral prosthesis valve thrombosis.
Transesophageal echocardiography: 2D evidence of mitral  prosthesis valve thrombosis Figure 3
Transesophageal echocardiography: 2D evidence of 
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mobile elements or thrombosis with preserved mobile
elements excursion [7-10].
The prevalence of pannus formation in patients reoper-
ated for prosthesis malfunction is about 25% and this
anatomical evidence explain the vulnerability to throm-
bosis.
Medical and surgery strategy are the two possible options
to treatment for acute thrombosis in prosthesis device
[11-13].
Mortality percentage during surgery for prosthetic throm-
bosis is till 60% (in unstable hemodinamic patients and
in emergency) while fibrinolitic agents involve a percent-
age of embolic complication between 9 and 15% with
recurrent thrombosis in 16% of cases.
Active blooding, hemorrhagic stroke, recent skull trauma
and uncontrolled high blood pressure are absolute con-
troindications to fibrinolitic treatment; endocarditic proc-
esses, intracardiac large thrombus and recent surgery
major operation or trauma are relative contraindication to
thrombolisis [11-14].
Adequate treatment choice is related with clinical status
(NYHA class), thrombus dimension, symptoms duration,
prosthesis type (one disk versus bileaflets), elements ipo-
mobility versus immobility and evidence of endocarditic
process with abscess and thrombosis.
In our case we report the successful fibrinolitic strategy with
rTPA in a patients with acute mitralic prosthesis valve throm-
bosis and ipomobility of one emidisk such as demonstrated
in some study in patients with bidisk valve prosthesis: stand-
ard indications to thrombolisis in acute thrombosis are
recent thrombus formation and only one disk blocked.
Surgery strategy is indicated in endocarditic process with
abscess and large dimensions thrombus or in old date
thrombus formation and if two disks prosthesis are involved.
In conclusion we could affirm that there aren't a consen-
sus agreement in therapeutic strategy but we may support
the approach of some authors that employ fibrinolisis in
patients without absolute or relative controindications
and if thrombus dimension is less than 1 cm otherwise
they make use of heparin therapy in non obstructive
thrombosis with successive transesophageal echocardiog-
raphy evaluation for the efficacy and the later indication
for thrombolisis or surgery treatment.
Surgery strategy should be reserved to patents with throm-
bus major than 1 cm, with or without endocarditis or in
patients with controindications to thrombolisis.
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